NSPR

New Leadership Appointment: Biobeat Technologies Ltd has appointed Raymond W. Cohen as the Chairman of the Board of Directors to help advance their innovative medical technology.

Innovative Technology: The company has developed a wearable, cuff-less ambulatory blood pressure monitoring system that collects various physiological data and has received FDA clearance for its patch device.

Cohen's Experience: Mr. Cohen brings over 40 years of experience in the life sciences industry, having successfully led companies like Axonics, Inc. and SoniVie, Ltd., both of which achieved significant financial milestones.

Future Applications: Cohen sees potential applications for Biobeat's technology in renal denervation and long-term monitoring of patients post-cardiac procedures, aiming to transform patient monitoring practices.

Appointment of Raymond W. Cohen: RxSight, Inc. has appointed Raymond W. Cohen to its Board of Directors, recognizing his extensive experience in medical technology and leadership roles, which will aid the company's growth strategy and expansion of its Light Adjustable Lens system for cataract surgery patients.

Cohen's Background and Vision: With over 40 years in the industry, Cohen has successfully led companies like Axonics, generating significant revenue and growth. He aims to leverage his expertise to enhance RxSight's position in the premium intraocular lens market and support its mission for improved patient outcomes.

Appointment of New Board Member: InspireMD, Inc. has appointed Raymond W. Cohen to its Board of Directors, bringing over 40 years of experience in medical technology and a successful track record in scaling operations and creating shareholder value.

Focus on Commercial Launch: Following the recent approval of their CGuard Prime carotid stent system, InspireMD is shifting its focus towards commercial launch and aims to leverage Cohen's expertise to enhance market penetration and long-term value creation.